Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04194619
Collaborator
(none)
400
32
80
12.5
0.2

Study Details

Study Description

Brief Summary

There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby.

The purpose of this National prospective study is to obtain greater insight into obstetrical complications associated with rare maternal vascular genetic disorders in order to improve prevention and to reduce risk of death.

In this context, experts and patient associations consider that there is a need to make real progress in the formulation of recommendations based on scientific data.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A National Prospective Cohort for Pregnancies in Patients With Rare Vascular Anomalies: COGRare5 Study
Anticipated Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2026

Outcome Measures

Primary Outcome Measures

  1. Occurrence of obstetrical complications among patients with rare vascular anomalies. [Maximum 21 months]

    The primary effectiveness endpoint is the occurrence of specific and serious obstetrical complications during and after the pregnancy period among patients with rare vascular anomalies. The questionnaire consists in collecting obstetric complications (interview time is about 15 minutes) every 3 months during and after pregnancy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women aged ≥ 18 years and ≤45 years at the time of inclusion

  • Pregnant and/or having given birth less than 1 month (≤ 30 days)

  • Clinically and/or radiological and/or molecular biology diagnosis of a rare vascular disease before or during pregnancy or one month after delivery.

  • Having been informed of all pertinent aspects of the study and provided oral non-opposition.

Exclusion Criteria:
  • Any person not fulfilling the inclusion criteria or refusing to take part in the study.

  • Major under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Médecine Interne et Maladies Vasculaires + Service Neuropédiatrie et neurochirurgie de l'enfant - CHU Angers Angers France 49933
2 Service de Médecine interne et immunologie clinique + Service de Médecine Vasculaire - Hôpital Saint André, CHU de Bordeaux Bordeaux France 33075
3 Service Pneumologie et Oncologie Thoracique - AP-HP Hôpital Ambroise Paré Boulogne-Billancourt France 92104
4 Centre de Référence pour la maladie de Rendu-Osler - Service Génétique Clinique - Hôpital Femme-Mère-Enfant - Hospices Civils de Lyon Bron France 69677
5 Service d'imagerie médicale - Neuroradiologie interventionnelle - Hôpital Neurologique P. Wertheimer - HCL Bron France 69677
6 Service d'Imagerie Pédiatrique et Fœtale et Consultation Pluridisciplinaire des Angiomes - Hôpital Femme-Mère-Enfant - HCL Bron France 69677
7 Service de Médecine Vasculaire - Hôpital de la Côte de Nacre Caen France 14033
8 Service Médecine Interne Estaing CHU de Clermont-Ferrand - Hôpital d'Estaing Clermont-Ferrand France 63000
9 CHU Dijon Bourgogne - Hôpital François Mitterrand Dijon France
10 Service de Médecine vasculaire et HTA - Hôpital Albert Calmette, CHRU de Lille Lille France 59037
11 Service Médecine interne - CHRU de Lille - Hôpital Claude Huriez Lille France 59037
12 CHU de Marseille - Hôpital de la Timone Marseille France 13385
13 Service Médecine Interne - Hôpital Saint-Eloi, CHU de Montpellier Montpellier France 34295
14 Service de neuroradiologie diagnostique et interventionnelle - CHU de Nancy, Hôpital St-Julien Nancy France 54035
15 Unité de neuro-interventionnelle CHU Nice, Hôpital Pasteur 2 Nice France 06001
16 Service de Neuroradiologie - AP-HP - Paris (Hôpital Lariboisière) Paris France 75010
17 Service de Lymphologie - Hôpital Cognacq-Jay - Paris Paris France 75015
18 Service de Cardiologie - Hôpital Bichat, AP-HP Paris France 75018
19 Service de Neuroradiologie Interventionnelle - Fondation Adolphe de Rothschild Paris France 75019
20 Service Radiologie-pneumologie interventionnelle - Hôpital Tenon AP-HP Paris France
21 Service de Génétique CHU de Poitiers Poitiers France 86021
22 Service de Pneumologie CHU de Rennes - Hôpital Pontchaillou Rennes France 35033
23 Unité de Génétique médicale, CHU de Rennes, Hôpital Sud Rennes France 35203
24 Service Médecine Interne - Médecine vasculaire - CHU de Rouen, Hôpital Charles Nicolle Rouen France 76000
25 Clinique cardiologique et des maladies vasculaires CHU de Nantes, Hôpital G. R. LAENNEC Saint-Herblain France 44800
26 Service de Médecine Vasculaire et Thérapeutique, Explorations Fonctionnelles Vasculaires - CHU de Saint-Etienne - Hôpital Nord Saint-Étienne France 42055
27 Service de Génétique Médicale, Hôpital de Hautepierre Strasbourg France 67098
28 Service de Neuroradiologie Interventionnelle - Hôpital Foch Suresnes France 92151
29 Service de Cardiologie _ Hôpital des Enfants (Purpan) Toulouse France 31026
30 Service de Médecine Interne + Service Médecine Vasculaire _ Hôpital RANGUEIL Toulouse France 31059
31 Service Pneumologie + Service de Dermatologie _ Hôpital Bretonneau Centre Hospitalier Régional Universitaire de TOURS Tours France
32 CHU de Nancy - Hôpitaux de Brabois Vandœuvre-lès-Nancy France 54511

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT04194619
Other Study ID Numbers:
  • 69HCL19_0380
First Posted:
Dec 11, 2019
Last Update Posted:
Dec 11, 2019
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 11, 2019